Kraematon Investment Advisors, Inc Wave Life Sciences Ltd. Transaction History
Kraematon Investment Advisors, Inc
- $95 Million
- Q4 2024
A detailed history of Kraematon Investment Advisors, Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Kraematon Investment Advisors, Inc holds 19,885 shares of WVE stock, worth $225,495. This represents 0.26% of its overall portfolio holdings.
Number of Shares
19,885
Previous 16,000
24.28%
Holding current value
$225,495
Previous $131,000
87.02%
% of portfolio
0.26%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding WVE
# of Institutions
166Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$206 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$114 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$110 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$76.4 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$69.9 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $985M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...